Cargando…

Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension

BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on...

Descripción completa

Detalles Bibliográficos
Autores principales: Tobita, Kazuki, Goda, Ayumi, Teruya, Koji, Nishida, Yuichiro, Takeuchi, Kaori, Kikuchi, Hanako, Inami, Takumi, Kohno, Takashi, Tashiro, Syoichi, Yamada, Shin, Satoh, Toru, Soejima, Kyoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382004/
https://www.ncbi.nlm.nih.gov/pubmed/37260024
http://dx.doi.org/10.1161/JAHA.122.026890
_version_ 1785080584703311872
author Tobita, Kazuki
Goda, Ayumi
Teruya, Koji
Nishida, Yuichiro
Takeuchi, Kaori
Kikuchi, Hanako
Inami, Takumi
Kohno, Takashi
Tashiro, Syoichi
Yamada, Shin
Satoh, Toru
Soejima, Kyoko
author_facet Tobita, Kazuki
Goda, Ayumi
Teruya, Koji
Nishida, Yuichiro
Takeuchi, Kaori
Kikuchi, Hanako
Inami, Takumi
Kohno, Takashi
Tashiro, Syoichi
Yamada, Shin
Satoh, Toru
Soejima, Kyoko
author_sort Tobita, Kazuki
collection PubMed
description BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on exercise tolerance remains unclear. We explored the factors contributing to exercise capacity and ventilatory efficiency in patients with hemodynamically normalized PAH after medical treatment. METHODS AND RESULTS: In total, 82 patients with PAH (age: median 46 [interquartile range, 39–51] years; male:female, 23:59) and mean pulmonary arterial pressure ≤30 mm Hg at rest were enrolled. The exercise capacity, indicated by the 6‐minute walk distance and peak oxygen consumption, and the ventilatory efficiency, indicated by the minute ventilation versus carbon dioxide output slope, were assessed using cardiopulmonary exercise testing with a right heart catheter. The mean pulmonary arterial pressure was 21 (17–25) mm Hg, and the 6‐minute walk distance was 530 (458–565) m, whereas the peak oxygen consumption was 18.8 (14.8–21.6) mLꞏmin(−1)ꞏkg(−1). The multivariate model that best predicted 6‐minute walk distance included peak arterial mixed venous oxygen content difference (β=0.46, P<0.001), whereas the best peak oxygen consumption predictors included peak cardiac output (β=0.72, P<0.001), peak arterial mixed venous oxygen content difference (β=0.56, P<0.001), and resting mean pulmonary arterial pressure (β=−0.25, P=0.026). The parameter that best predicted minute ventilation versus carbon dioxide output slope was the resting mean pulmonary arterial pressure (β=0.35, P=0.041). Quadriceps muscle strength was moderately correlated with exercise capacity (6‐minute walk distance; ρ=0.57, P<0.001; peak oxygen consumption: ρ=0.56, P<0.001) and weakly correlated with ventilatory efficiency (ρ=−0.32, P=0.007). CONCLUSIONS: Central and peripheral factors are closely related to impaired exercise tolerance in patients with hemodynamically normalized PAH.
format Online
Article
Text
id pubmed-10382004
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103820042023-07-29 Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension Tobita, Kazuki Goda, Ayumi Teruya, Koji Nishida, Yuichiro Takeuchi, Kaori Kikuchi, Hanako Inami, Takumi Kohno, Takashi Tashiro, Syoichi Yamada, Shin Satoh, Toru Soejima, Kyoko J Am Heart Assoc Original Research BACKGROUND: The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on exercise tolerance remains unclear. We explored the factors contributing to exercise capacity and ventilatory efficiency in patients with hemodynamically normalized PAH after medical treatment. METHODS AND RESULTS: In total, 82 patients with PAH (age: median 46 [interquartile range, 39–51] years; male:female, 23:59) and mean pulmonary arterial pressure ≤30 mm Hg at rest were enrolled. The exercise capacity, indicated by the 6‐minute walk distance and peak oxygen consumption, and the ventilatory efficiency, indicated by the minute ventilation versus carbon dioxide output slope, were assessed using cardiopulmonary exercise testing with a right heart catheter. The mean pulmonary arterial pressure was 21 (17–25) mm Hg, and the 6‐minute walk distance was 530 (458–565) m, whereas the peak oxygen consumption was 18.8 (14.8–21.6) mLꞏmin(−1)ꞏkg(−1). The multivariate model that best predicted 6‐minute walk distance included peak arterial mixed venous oxygen content difference (β=0.46, P<0.001), whereas the best peak oxygen consumption predictors included peak cardiac output (β=0.72, P<0.001), peak arterial mixed venous oxygen content difference (β=0.56, P<0.001), and resting mean pulmonary arterial pressure (β=−0.25, P=0.026). The parameter that best predicted minute ventilation versus carbon dioxide output slope was the resting mean pulmonary arterial pressure (β=0.35, P=0.041). Quadriceps muscle strength was moderately correlated with exercise capacity (6‐minute walk distance; ρ=0.57, P<0.001; peak oxygen consumption: ρ=0.56, P<0.001) and weakly correlated with ventilatory efficiency (ρ=−0.32, P=0.007). CONCLUSIONS: Central and peripheral factors are closely related to impaired exercise tolerance in patients with hemodynamically normalized PAH. John Wiley and Sons Inc. 2023-06-01 /pmc/articles/PMC10382004/ /pubmed/37260024 http://dx.doi.org/10.1161/JAHA.122.026890 Text en © 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Tobita, Kazuki
Goda, Ayumi
Teruya, Koji
Nishida, Yuichiro
Takeuchi, Kaori
Kikuchi, Hanako
Inami, Takumi
Kohno, Takashi
Tashiro, Syoichi
Yamada, Shin
Satoh, Toru
Soejima, Kyoko
Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title_full Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title_fullStr Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title_full_unstemmed Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title_short Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
title_sort exercise capacity and ventilatory efficiency in patients with pulmonary arterial hypertension
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382004/
https://www.ncbi.nlm.nih.gov/pubmed/37260024
http://dx.doi.org/10.1161/JAHA.122.026890
work_keys_str_mv AT tobitakazuki exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT godaayumi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT teruyakoji exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT nishidayuichiro exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT takeuchikaori exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT kikuchihanako exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT inamitakumi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT kohnotakashi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT tashirosyoichi exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT yamadashin exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT satohtoru exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension
AT soejimakyoko exercisecapacityandventilatoryefficiencyinpatientswithpulmonaryarterialhypertension